Cargando…
Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening
BACKGROUND: Recent guidelines recommend consideration of germline testing for all newly diagnosed pancreatic ductal adenocarcinoma (PDAC). The primary aim of this study was to determine the burden of hereditary cancer susceptibility in PDAC. A secondary aim was to compare genetic testing uptake rate...
Autores principales: | Cremin, Carol, Lee, Michael Kuan‐Ching, Hong, Quan, Hoeschen, Carolyn, Mackenzie, Anna, Dixon, Katherine, McCullum, Mary, Nuk, Jennifer, Kalloger, Steve, Karasinska, Joanna, Scudamore, Charles, Kim, Peter T. W., Donnellan, Fergal, Lam, Eric C. S., Lim, Howard J., Neben, Cynthia L., Stedden, Will, Zhou, Alicia Y., Schaeffer, David F., Sun, Sophie, Renouf, Daniel J., Schrader, Kasmintan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286471/ https://www.ncbi.nlm.nih.gov/pubmed/32255556 http://dx.doi.org/10.1002/cam4.2973 |
Ejemplares similares
-
CDKN2A founder mutation in pancreatic ductal adenocarcinoma patients without cutaneous features of Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome
por: Cremin, Carol, et al.
Publicado: (2018) -
Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication
por: Pollard, Samantha, et al.
Publicado: (2020) -
Base excision repair deficiency signatures implicate germline and somatic MUTYH aberrations in pancreatic ductal adenocarcinoma and breast cancer oncogenesis
por: Thibodeau, My Linh, et al.
Publicado: (2019) -
Advancing the Care of Pancreatic Cancer Patients: Moving Beyond Just
Tumour Tissue
por: Kalloger, Steve E, et al.
Publicado: (2021) -
Oncology Clinic-Based Hereditary Cancer Genetic Testing in a Population-Based Health Care System
por: Richardson, Matthew, et al.
Publicado: (2020)